Vaccin gör människor sjuka - (Autism, Adhd, utvecklingsstörningar, allergier etc.)

In my view, this DNA could contribute to rare but serious side effects, such as deaths from cardiac arrest. There have been numerous cases of suspicious deaths following vaccination, and while it’s hard to prove causation, this DNA presents a plausible mechanism.

This DNA can integrate into the genomic DNA of the cells that received the vaccine. We do this in the lab all the time: we take pieces of DNA, mix them with a lipid complex like the Pfizer vaccine, and a lot of it gets into the cells. Once it’s in, it can become a permanent fixture of the cell and all its progeny.

This raises alarm bells for me. The DNA being in the vaccine is different from RNA because it can be permanent. This poses a real hazard for genome modification of long-lived cells, such as stem cells. Theoretically, it could cause sustained autoimmune responses or even future cancer risks, depending on where the foreign DNA integrates. While these events may be rare, the risk is not zero and needs to be investigated.

Phillip Buckhaults, Ph.D.
Title: Professor
Department: Drug Discovery & Biomedical Sciences (DDBS)
College of Pharmacy
Email: buckhaul@cop.sc.edu
Phone: 803-777-3621
Office: Jones Physical Sciences Center
745 Main Street - PSC 620
Columbia, SC 29208

Phillip Buckhaults portrait

Education
Ph.D. Biochemistry and Molecular Biology, University of Georgia, 1996
M.S. Biochemistry and Molecular Biology, University of California, San Diego, 1991
B.S. Chemistry, University of South Florida, 1988

Background
Phillip Buckhaults, Ph.D., is an experienced molecular biologist and cancer geneticists who has extensive experience with next-gen sequencing applications for global gene expression analysis and gene mutation detection.

Buckhaults characterized the expression landscapes of colon tumors to identify signatures of recurrence and the mutation landscapes of breast and colon tumors to identify novel cancer genes, and he has profiled cancer gene mutation signatures in melanomas to determine novel therapeutic modalities based on targeting PI3K and BRAF pathways.

Buckhaults uses somatic cell knockout technology to characterized variant alleles in human cells and has discovered novel functions of a polymorphism in the TP53 gene.

Misinformation alleging DNA contamination in the COVID 19 vaccines
Some laboratories have attempted to investigate the amount of DNA in COVID-19 vaccines. This has led to a number of incorrect media and online reports circulated on social media about the safety of mRNA COVID-19 vaccines. These reports are based on studies that currently fall short of the scientific rigor expected in pharmaceutical testing and are contributing to the spread of vaccine misinformation.

Concerns with these studies include:
Selective reporting and method validation
Some laboratories have chosen to report DNA levels using a test called fluorometry, which is known to overestimate DNA levels in the presence of mRNA. This is because the fluorescent dye used in this test binds to both DNA - which may be present in minute amounts - and mRNA, which is the main ingredient in the COVID-19 vaccines. This leads to incorrect DNA levels being reported in these tests.
The physical reference materials were not adequately defined.

Issues with samples
Some of these studies use a very small sample number, for example only three vials. The studies also used samples that were well past their use by date. Some samples had already been opened and used. These samples were not suitable for testing.
The provenance of the samples is also not clear. This means that significant information is not known about the vials used:
where the vials were sourced
their location, custody, or temperature before or during testing.
Regulatory testing is conducted within tightly controlled frameworks to ensure that test samples cannot be manipulated, and results can be relied upon. Processes that do not ensure traceability and certainty about the integrity and provenance of test samples impact the reliability of findings.
Vaccine vials are required to be shipped via ‘cold chain’ where the temperature must be within a specified range and monitored during transportation. Vials shipped to Australia must adhere to these requirements and the TGA checks that this is done. However, the samples used in these studies were not kept in cold chain and usually did not have temperature loggers with them.